US2012071552A1PendingUtilityA1
Zinc-Monocysteine Complex and Method Of Using Zinc-Cysteine Complexes
Est. expiryJan 7, 2020(expired)· nominal 20-yr term from priority
A61P 39/06A61K 31/315C07C 323/58C07C 323/52
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of providing zinc to a subject in need of treatment includes administering to the subject an effective amount of a zinc-cysteine complex. The zinc-cysteine complex is preferably a zinc-monocysteine complex. The complexes of zinc-cysteine of the present invention increase the activity of antioxidant enzymes catalase and glutathione peroxidase, and the antioxidant protein metallothionein. The complexes of zinc-cysteine of the present invention protect retinal pigment epithelial cells from increasing hydrogen peroxide concentrations.
Claims
exact text as granted — not AI-modified1 . A zinc-monocysteine complex.
2 . The zinc-monocysteine complex of claim 1 , formed by the following method:
heating a 1:2 gram ratio of L-cysteine and Zn (metal) at about 85 degrees C. for about 2 hours; removing any solid residues by filtration; evaporating to dryness.
3 . The zinc-monocysteine complex of claim 1 , comprising C 3 H 5 NSO 2 Zn.
4 . A method of providing zinc to a subject in need of treatment comprising administering to the subject an effective amount of a zinc-cysteine complex.
5 . The method of claim 4 , wherein the zinc-cysteine complex is a zinc-monocysteine complex.
6 . The method of claim 4 , wherein the zinc-cysteine complex is administered orally.
7 . The method of claim 4 , wherein the amount administered is 15-45 mg bioavailable zinc.
8 . The method of claim 4 , wherein the complex of zinc-cysteine increases the activity of antioxidant enzymes catalase and glutathione peroxidase, and the antioxidant protein metallothionein.
9 . The method of claim 4 , wherein the complex of zinc-cysteine protects retinal pigment epithelial cells from increasing hydrogen peroxide concentrations.
10 . A zinc-cysteine complex suitable for oral ingestion by a human subject.
11 . The zinc-cysteine complex of claim 10 , formed by the following method:
heating a 1:2 gram ratio of L-cysteine and Zn (metal) at about 85 degrees C. for about 2 hours; collecting the product by filtration; evaporating to dryness.
12 . The zinc-cysteine complex of claim 10 , comprising C 3 H 5 NSO 2 Zn.
13 . The zinc-monocysteine complex of claim 1 , comprising the zinc-cysteine complex shown in the equation above the abstract in the paper attached to U.S. patent application Ser. No. 09/756,152.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.